Surmodics | SRDX - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Abbott USD 1.74B 23.39B 2025-09
Align Technology USD 71.75M 736K 2025-12
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 135.7M 2.44M 2025-09
Artivion USD 47.84M 468K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Boston Scientific USD 1.48B 1.46B 2025-06
EDAP TMS EUR 37.39M 0 2025-09
Edwards Lifesciences USD 580.7M 7.2M 2025-09
Haemonetics USD 46.83M 82K 2025-12
Heron Therapeutics USD 188.31M 4.99M 2025-12
J&J USD 2.41B 584K 2025-09
Merit Medical Systems USD 59.29M 72K 2025-09
Mesa Laboratories USD 349.53M 3.53M 2024-09
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Option Care Health USD 156.86M 6.89M 2025-12
Stryker USD 382.4M 93K 2025-12
Surmodics USD 14.3M 13.58M 2025-06
Trinity Biotech USD 385.2M 382.82M 2025-06